HOME >> BIOLOGY >> NEWS
A decisive step toward a cure for insulin dependent diabetes

Montreal, July 15, 2007 A diagnosis of type I diabetes means a life sentence of medical follow-up. While treatments have become simpler and less restrictive in recent years, they are still a burden, especially for young patients. The latest study published in the journal Nature by Dr. Constantin Polychronakos, Director of the Pediatric Endocrinology Department at the MUHC, in collaboration with Dr. Hakon Hakonarson, Director of the Centre for Applied Genomics of the Childrens Hospital of Philadelphia (CHOP), provides hope that this situation will evolve in the long term toward a cure for this disease.

Using innovative high-density DNA microchip technology, which can test 550,000 genes in a single analysis, Drs. Polychronakos and Hakonarson have detected a new gene involved in type I diabetes. To date, only 4 of the genes responsible for this disease had been identifiedthis now makes 5. We believe there are approximately 15 genes involved in insulin-dependent diabetes; our study proved that high-density DNA microchips are effective and we hope to use them to identify all of these genes in the near future, explained Dr. Polychronakos, also a professor of pediatrics and human genetics at McGill University.

The causes of type I diabetes are still a relative mystery. It is estimated that approximately 50% are genetic and 50% environmental, which is why the validation of a new, extremely powerful analysis method and the identification of a new gene involved is extremely important. The newly discovered gene goes by the elegant name KIAA0350. While its precise role is not yet known, it is activated mainly in the immune system; this finding makes perfect sense, since type I diabetes is an autoimmune diseasethe patients immune system destroys its own insulin-producing pancreatic cells, which it mistakenly identifies as foreign bodies.

The identification of these genes will help advance research on two fronts: prevention and treatment. Prevent
'"/>

Contact: Isabelle Kling
isabelle.kling@muhc.mcgill.ca
514-934-1934
McGill University Health Centre
15-Jul-2007


Page: 1 2

Related biology news :

1. Petition for increased EU funding sees decisive response from scientific community
2. Radar tracking reveals that butterflies follow decisive flight paths
3. NIH should take decisive steps to promote independence, originality
4. Bursts of waves drive immune system soldiers toward invaders
5. Cloned pigs help scientists towards a breakthrough in Alzheimers
6. Paving the way toward a vaccine against Alzheimers disease
7. Latest strategies for moving research toward a cure for diabetes explored at global scientific forum
8. Progress toward a targeted therapy for a specific form of leukemia
9. Tiny clue reveals new path toward heart disease
10. Progress toward artificial photosynthesis?
11. MIT engineer works toward clean water, more

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2018)... ... 12, 2018 , ... uBiome, the leader in microbial genomics, ... its Medical Advisory Board. Joining the board of leading scientists and doctors from ... the surgical treatments of ulcerative colitis and Crohn's disease. The appointment will help ...
(Date:10/11/2018)... ... , ... Exalto Bearings UK, the manufacturer of high quality rubber-lined ... as Business Manager. , Cosgrove has over 30 years of experience within the engineering ... the Derby UK facility. , “We are pleased to have Mike join our team,” ...
(Date:10/11/2018)... (PRWEB) , ... October 11, 2018 , ... ... is the vision behind the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). ... of projects designed to advance biopharmaceutical manufacturing and workforce development in the United ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... ... October 02, 2018 , ... ... solutions for biopharmaceutical R&D, today announced a new out-of-the-box integration of the ... a leading international pharmaceutical and laboratory equipment supplier. This enables the automatic ...
(Date:9/29/2018)... GARDEN GROVE, Calif. (PRWEB) , ... September 29, ... ... Voxx.Gateway, an analytics product enabling mid-level and early-stage companies to access the power ... working to make our solutions available to a broader market that didn’t necessarily ...
(Date:9/27/2018)... ... September 26, 2018 , ... Consumers adopting new health care ... physicians, according to a new Zeldis Research and Schlesinger Group study, “The Consumerization ... consumer adoption of fitness and health wearables, remote monitoring, patient portals and other ...
(Date:9/27/2018)... , ... September 27, 2018 , ... ... in Cambridge, MA, announce today that Holotype HLA and other Omixon products will ... meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. ...
Breaking Biology Technology:
Cached News: